fingolimod hydrochloride
fingolimod hydrochloride is listed in the FDA National Drug Code directory with 2 NDC codes. Available dosage form: powder.
Drug details
- Generic Name
- fingolimod hydrochloride
- Sponsor
- Novartis Pharma Schweizerhalle AG
- NDC Codes
- 2
- Dosage Forms
- POWDER
- Active Ingredients
- FINGOLIMOD HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. Fingolimod capsules are a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. ( 1 )